Advisory Board
The Advisory Board of the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University plays a vital role in shaping the department’s strategic direction. Comprising leaders from academia, industry, healthcare, and government, the board provides expert guidance on educational programs, research initiatives, and innovation strategies. Their insights help ensure the department remains at the forefront of biomedical engineering, aligning its goals with evolving global health challenges and industry needs. Through their support and advocacy, the board strengthens connections between the department and the broader biomedical community, enhancing opportunities for students, faculty, and collaborative partners.
2025-2026 Board Members
![]() | Rafel V. Andino M.S., MBA Vice President, Engineering & Manufacturing Clearside Biomedical, Inc. ME 1988 (Georgia Tech) |
![]() | Caleb M. Appleton Senior Vice President & General Manager of Global Subscriptions TuneIn BME 2015 |
![]() | Mario Ball US Director of Sales Strategy and Commercial Execution Boston Scientific – Cardiology Group BME ’07 |
![]() | Chief of Staff |
![]() | Medical Director |
![]() | Ambika Bumb, Ph.D. Deputy Executive Director Bipartisan Commission on Biodefence BMED ’05 Start of Term - Fall 2024 |
![]() | Elizabeth Cosgriff-Hernandez, Ph.D. Professor, Cullen Trust for Higher Education Endowed Professorship |
![]() | Senior Strategic Account Manager BME 2005 |
![]() | Gautam Goel, Ph.D. Chief Data Science Officer hC Bioscience, Inc. MS BIOE ’06; PHD BIOE ’09 |
![]() | CEO Advisory Board Chair |
![]() | Product Leader Ph.D. BioE (BME) 2010 |
![]() | Christopher Hermann, M.D., Ph.D. Chief Executive Officer and Founder BME 2006, Ph.D. BME 2011 |
![]() | Angela Holmes CEO OmniScience ME ’96 |
![]() | Shawna Khouri Director, Virtual Health Tulsa Innovation Labs BME ’12, ’14 |
![]() | Allen H. and Constance T. Ford Professor and Chair |
![]() | Xavier Lefebvre, Ph.D. Global Vice President ChBE 1992 (Georgia Tech) |
![]() | Chief Medical Officer M.D. 2002 (Emory) |
![]() | Dev Mandavia VP Strategy and Corporate Development OXOS Medical BME ’18 |
![]() | Professor of the Practice |
![]() | President and CEO |
![]() | Josh Vose CEO Tulavi Therapeutics CHE ’01 Start of Term - Fall 2024 |
![]() | Vice President, Market Development and Head of Clinical Care NBB 2001 (Emory) |
![]() | Chief Operations Officer BME 2007 |
![]() | Global Innovation Manager |